For many people with elevated BMI, the word “treatment” in the context of weight loss immediately brings surgery to mind. The reality is that non-surgical options have advanced significantly in recent years, and for a substantial proportion of patients, they produce meaningful, sustained results without the risks and recovery that surgical procedures involve.
The caveat is equally important: not all non-surgical approaches are equally effective. Many popular options — from commercial diet programmes to over-the-counter supplements — have limited clinical evidence behind them. What follows focuses on the options with genuine research support.
What Makes a Non-Surgical Option Actually Work
Effective non-surgical weight loss is not about a single intervention. The evidence consistently points to a combination of factors:
A clinical tool that addresses the physiological barriers to weight loss — whether a device that reduces stomach capacity or a medication that regulates appetite. Structured dietary guidance that creates a sustainable caloric deficit. Behavioural support that addresses the habits, patterns, and psychological dimensions of eating. Regular medical monitoring that adjusts the programme based on individual response.
Options that deliver only one of these components — a medication without dietary guidance, or a diet plan without clinical support — produce considerably weaker long-term outcomes than integrated programmes.
The Allurion Gastric Balloon
The Allurion Gastric Balloon is the most clinically advanced non-surgical device option currently available for weight management in Ottawa.
Unlike traditional gastric balloons — which require endoscopy for both placement and removal — the Allurion Balloon is swallowed as a capsule, requires no sedation, and deflates and passes naturally after approximately 16 weeks. The placement appointment takes 15 minutes as an outpatient visit.
Once inflated to approximately 550ml in the stomach, the balloon reduces functional capacity, creates persistent early satiety, and supports the caloric restriction needed to initiate meaningful weight loss. Clinical data from over 1,770 patients shows average total body weight loss of 10–15% across the six-month programme.
Ottawa Health Center is the only Allurion-certified provider in the Ottawa and Gatineau region.
The balloon is most effective when delivered as part of the full six-month programme — including dietary coaching, regular check-ins, and behavioural support. Patients who complete the full programme show 95% weight maintenance at 12 months.
Suitable for: Adults with a BMI between 27 and 40 who want to avoid surgery.
Medically Supervised Nutrition Programmes
A structured nutrition programme designed and monitored by a medical team is distinct from a commercial diet plan. The clinical component — regular monitoring of weight, nutritional status, and metabolic markers — allows the programme to be adjusted based on how the individual body is responding.
These programmes work as a standalone intervention for patients in the lower BMI range, and as the dietary foundation of more intensive interventions for patients with higher BMI. The quality of the dietary component directly influences outcomes regardless of which other interventions are used.
Suitable for: Adults across the BMI range, either as a primary intervention or in combination with a clinical tool.
GLP-1 Receptor Agonist Medications
GLP-1 medications — semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda) — are the most significant pharmacological development in weight management in a generation. They work by mimicking a gut hormone that regulates appetite and slows gastric emptying, producing a sustained reduction in food intake.
Clinical trials have shown average weight loss of 10–15% of body weight with weekly semaglutide injections over 68 weeks. Results are meaningful, though they vary considerably between individuals.
The important caveat: weight regain is common when GLP-1 medications are discontinued without supporting behavioural change in place. They are most effective as part of a programme that includes dietary and lifestyle support — not as a standalone treatment.
Suitable for: Adults with a BMI of 30 or above, or 27 or above with weight-related conditions. Requires ongoing medical supervision.
Very Low Calorie Diets Under Medical Supervision
Very low calorie diets (VLCDs) — typically 800 calories per day or below — produce rapid initial weight loss and are used in specific clinical contexts, usually as preparation for surgery or as a short-term intervention within a supervised programme.
They are not appropriate without medical supervision. Used within a clinical programme with proper monitoring and transition planning, they can be effective in specific circumstances.
Suitable for: Select patients within a medically supervised programme where rapid initial weight loss is a clinical objective.
Behavioural and Psychological Interventions
The behavioural dimension of weight management is frequently underestimated. For many patients, the factors driving weight gain are not primarily physiological — they involve stress eating, habitual patterns, emotional relationships with food, and environmental cues that persist regardless of which physical intervention is used.
Cognitive behavioural therapy, structured behavioural programmes, and psychological support significantly improve long-term outcomes across all weight loss interventions. They address the reasons why weight returns, not just the mechanisms of initial loss.
Suitable for: All patients as a component of a comprehensive programme. Particularly important for patients with a history of weight cycling.
What Is Not on This List
Several popular approaches are absent from this guide because the evidence for meaningful, sustained weight loss is weak: commercial meal replacement programmes without clinical oversight, over-the-counter weight loss supplements, detox programmes, and most single-component diet plans.
This is not to say these approaches produce no short-term results — many do. The problem is durability. Without addressing the physiological and behavioural factors that drive weight regain, initial results are rarely maintained.
Finding the Right Option in Ottawa
The right non-surgical weight loss option depends on your BMI, health profile, previous attempts, and what you are willing to commit to. There is no universal answer.
Ottawa Health Center offers free consultations to help you work through exactly this question. Our medical team will review your situation, explain the options appropriate for your profile, and give you an honest assessment of what is realistic — before any decisions are made.
Medically Reviewed
Ottawa Health Center Medical Team
All content at Ottawa Health Center is reviewed for medical accuracy before publication.
Frequently Asked Questions
What is the most effective non-surgical weight loss option?
Can non-surgical methods produce lasting weight loss?
Is the Allurion Balloon the best non-surgical weight loss option in Ottawa?
How do GLP-1 medications compare to the Allurion Balloon?
Do I need a referral to access non-surgical weight loss treatment in Ottawa?
Are non-surgical weight loss options covered by OHIP or private insurance?
Clinical Sources
- Dombrowski SU, et al. Long-term maintenance of weight loss with non-surgical interventions in obese adults. BMJ, 2014.
- Allurion Technologies. Elipse Gastric Balloon Programme: Clinical Evidence Summary. 2023.
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM, 2021.
- World Health Organization. Obesity and Overweight Fact Sheet. WHO, 2024.
Take the First Step Today
A free consultation with our medical team is the right place to start. We will assess your situation and recommend the programme that fits your goals and health profile.